A detailed history of Kfa Private Wealth Group, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Kfa Private Wealth Group, LLC holds 1,718 shares of ABBV stock, worth $288,211. This represents 0.16% of its overall portfolio holdings.

Number of Shares
1,718
Previous 1,299 32.26%
Holding current value
$288,211
Previous $222,000 52.7%
% of portfolio
0.16%
Previous 0.11%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 18, 2024

BUY
$163.84 - $199.33 $68,648 - $83,519
419 Added 32.26%
1,718 $339,000
Q2 2024

Aug 07, 2024

SELL
$154.79 - $180.76 $164,077 - $191,605
-1,060 Reduced 44.93%
1,299 $222,000
Q1 2024

May 01, 2024

BUY
$159.82 - $182.1 $33,082 - $37,694
207 Added 9.62%
2,359 $429,000
Q4 2023

Feb 02, 2024

BUY
$137.6 - $154.97 $1,100 - $1,239
8 Added 0.37%
2,152 $333,000
Q3 2023

Oct 25, 2023

SELL
$133.59 - $154.65 $801 - $927
-6 Reduced 0.28%
2,144 $319,000
Q2 2023

Jul 18, 2023

SELL
$132.51 - $164.9 $54,726 - $68,103
-413 Reduced 16.11%
2,150 $289,000
Q1 2023

May 05, 2023

BUY
$144.61 - $166.54 $100,359 - $115,578
694 Added 37.13%
2,563 $408,000
Q4 2022

Jan 31, 2023

SELL
$138.31 - $165.87 $37,067 - $44,453
-268 Reduced 12.54%
1,869 $302,000
Q3 2022

Nov 02, 2022

SELL
$134.21 - $153.93 $1,744 - $2,001
-13 Reduced 0.6%
2,137 $287,000
Q2 2022

Jul 18, 2022

SELL
$137.62 - $174.96 $9,358 - $11,897
-68 Reduced 3.07%
2,150 $329,000
Q1 2022

May 02, 2022

BUY
$131.98 - $163.75 $923 - $1,146
7 Added 0.32%
2,218 $360,000
Q4 2021

Jan 26, 2022

BUY
$107.43 - $135.93 $752 - $951
7 Added 0.32%
2,211 $299,000
Q3 2021

Oct 18, 2021

BUY
$106.4 - $120.78 $17,556 - $19,928
165 Added 8.09%
2,204 $238,000
Q2 2021

Jul 22, 2021

BUY
$105.21 - $117.21 $12,730 - $14,182
121 Added 6.31%
2,039 $230,000
Q1 2021

May 06, 2021

BUY
$102.3 - $112.62 $511 - $563
5 Added 0.26%
1,918 $208,000
Q4 2020

Mar 08, 2021

BUY
$80.49 - $108.67 $153,977 - $207,885
1,913 New
1,913 $205,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $297B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Kfa Private Wealth Group, LLC Portfolio

Follow Kfa Private Wealth Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kfa Private Wealth Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Kfa Private Wealth Group, LLC with notifications on news.